BPTH Quote, Trading Chart, Bio-Path Holdings Inc.
home / stock / bpth / bpth quote
$6.48 Last:
-0.15% Change Percent:
$6.38 Open:
$6.48 Previous Close:
$6.48 High:
$6.31 Low:
60,899 Volume:
06/18/2021 04:42:30 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BPTH Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-18 | 6.38 | 6.48 | 6.48 | 6.31 | 60,899 |
| 2021-06-17 | 6.47 | 6.49 | 6.61 | 6.4 | 48,134 |
| 2021-06-16 | 6.4 | 6.47 | 6.63 | 6.32 | 101,915 |
| 2021-06-15 | 6.72 | 6.43 | 6.8 | 6.3 | 139,098 |
| 2021-06-14 | 6.85 | 6.79 | 6.92 | 6.56 | 128,547 |
| 2021-06-11 | 6.76 | 6.85 | 7 | 6.3 | 276,890 |
| 2021-06-10 | 6.2 | 6.67 | 7.1999 | 6.15 | 613,994 |
| 2021-06-09 | 5.95 | 6.15 | 6.42 | 5.95 | 147,005 |
| 2021-06-08 | 6.02 | 6 | 6.13 | 5.92 | 101,101 |
| 2021-06-07 | 5.7 | 6.04 | 6.14 | 5.7 | 178,221 |
| 2021-06-04 | 5.88 | 5.77 | 6.04 | 5.71 | 139,971 |
| 2021-06-03 | 6.16 | 5.92 | 6.16 | 5.7 | 176,173 |
| 2021-06-02 | 5.83 | 6.16 | 6.78 | 5.66 | 809,948 |
| 2021-06-01 | 5.71 | 5.81 | 5.8799 | 5.68 | 57,690 |
| 2021-05-31 | 5.71 | 5.7 | 5.9 | 5.45 | 180,197 |
| 2021-05-28 | 5.71 | 5.7 | 5.9 | 5.45 | 179,707 |
| 2021-05-27 | 5.62 | 5.68 | 5.7 | 5.41 | 109,413 |
| 2021-05-26 | 5.49 | 5.62 | 5.6725 | 5.46 | 69,243 |
| 2021-05-25 | 5.61 | 5.5 | 5.76 | 5.45 | 105,105 |
| 2021-05-24 | 5.92 | 5.6 | 6.17 | 5.6 | 225,925 |
Bio-Path Holdings Inc. Company Name:
BPTH Stock Symbol:
NASDAQ Market:
Bio-Path Holdings Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
HOUSTON, May 14, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial r...
-
HOUSTON, May 07, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a ...
-
HOUSTON, April 22, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced the publication of...